Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1009119-82-7

Post Buying Request

1009119-82-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1,2-PYRROLIDINEDICARBOXYLIC ACID, 2,2'-[[1,1'-BIPHENYL]-4,4'-DIYLBIS(2-OXO-2,1-ETHANEDIYL)] BIS[1-(1,1-DIMETHYLETHYL)] ESTER, (2S)-

    Cas No: 1009119-82-7

  • No Data

  • 1 Gram

  • Metric Ton/Day

  • Afine Chemicals Limited
  • Contact Supplier
  • 1,2-Pyrrolidinedicarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester

    Cas No: 1009119-82-7

  • No Data

  • No Data

  • No Data

  • Chemlyte Solutions
  • Contact Supplier
  • (2S,2'S)-O'2,O2-([1,1'-biphenyl]-4,4'-diylbis(2-oxoethane-2,1-diyl))1-di-tert-butylbis(pyrrolidine-1,2-dicarboxylate)

    Cas No: 1009119-82-7

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

1009119-82-7 Usage

General Description

1,2-Pyrrolidinedicarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester, (2S)- is a complex chemical compound with a long name that describes its structure. It is an ester formed from 1,2-pyrrolidinedicarboxylic acid and 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)]. It contains a chiral center with a (2S)- configuration, indicating its stereochemistry. 1,2-Pyrrolidinedicarboxylic acid, 2,2'-[[1,1'-biphenyl]-4,4'-diylbis(2-oxo-2,1-ethanediyl)] bis[1-(1,1-dimethylethyl)] ester, (2S)- may have various pharmaceutical or industrial applications, as esters can be used in drug formulation, as flavorings, or as solvents, among other uses.

Check Digit Verification of cas no

The CAS Registry Mumber 1009119-82-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,1,1 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1009119-82:
(9*1)+(8*0)+(7*0)+(6*9)+(5*1)+(4*1)+(3*9)+(2*8)+(1*2)=117
117 % 10 = 7
So 1009119-82-7 is a valid CAS Registry Number.

1009119-82-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,2'S)-O'2,O2-([1,1'-biphenyl]-4,4'-diylbis(2-oxoethane-2,1-diyl))1-di-tert-butylbis(pyrrolidine-1,2-dicarboxylate)

1.2 Other means of identification

Product number -
Other names 1,?2-?Pyrrolidinedicarboxy?lic acid, 2,?2'-?[[1,?1'-?biphenyl]?-?4,?4'-?diylbis(2-?oxo-?2,?1-?ethanediyl)?] bis[1-?(1,?1-?dimethylethyl)?] ester, (2S)?-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1009119-82-7 SDS

1009119-82-7Relevant articles and documents

MICRO-ELECTROLYSIS REACTOR FOR ULTRA FAST, OXIDANT FREE, C-C COUPLING REACTION AND SYNTHESIS OF DACLATASVIR ANALOGS THEREOF

-

, (2020/12/01)

The present invention relates to a continuous micro-electro-flow reactor system for ultra-fast, oxidant free, C—C coupling reaction for making symmetrical biaryls and analogs thereof. This invention further relates to the said process for preparation of antiviral drug, daclatasvir of general formula I.

PROCESS FOR THE PREPARATION OF DACLATASVIR DIHYDROCHLORIDE AND ITS INTERMEDIATES

-

Paragraph 0037; 0039, (2018/10/04)

The present invention relates to an improved process for the preparation of Daclatasvir dihydrochloride by using compound salt of formula (VIIc).

Preparation method of daclatasvir and its intermediate

-

Paragraph 0043; 0061; 0067; 0068; 0069, (2017/08/28)

The invention discloses a preparation method of daclatasvir and its intermediate. The invention provides a preparation method of a daclatasvir intermediate I. The method includes the step of: in an organic solvent or under a solvent-free condition, subjec

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1009119-82-7